QR Group analyzes the main points of the proposal and advises companies on the regulatory impacts for registration and marketing in Brazil
ANVISA Opens Public Consultation to Update Rules for Medical Cannabis Products In July 2025, ANVISA opened a new Public Consultation to update RDC No. 327/2019, which currently regulates cannabis products for medical use in Brazil. The initiative aims to review technical and operational criteria to keep up with scientific evolution, ensure greater regulatory certainty, and […]
Regularization of Cannabis-Based Products for Veterinary Use
Understand how the new measure impacts the regulation of veterinary products and how QR Group can help companies in the process. On October 30, ANVISA’s Collegiate Board approved a measure that allows the regularization of cannabis-based products for veterinary use by the Ministry of Agriculture and Livestock (MAPA). The decision amends Ordinance SVS/MS 344/1998, allowing […]
